New Leaf Venture Partners, L.L.C.
New Leaf Venture Partners, L.L.C. is a venture capital firm headquartered in New York, NY, United States. Founded in 2005, the firm specializes in investments in the healthcare and life sciences sectors, particularly targeting innovative biopharmaceutical, medical device, and diagnostic companies. The firm manages several venture funds and serves a wide range of institutional and strategic investors seeking growth opportunities in transformative healthcare solutions. As of 2025, it holds a portfolio value of approximately $52.95 million and maintains a team of experienced professionals with deep industry expertise.
Investment Strategy
New Leaf Venture Partners focuses on early- to late-stage investments in innovative healthcare and life sciences companies, with a particular emphasis on biopharmaceuticals, medical devices, and diagnostics. The firm seeks to partner with entrepreneurs whose companies have the potential for significant impact on patient outcomes and strong commercial potential. By leveraging deep industry connections and an experienced management team, New Leaf provides capital, strategic support, and operational guidance to portfolio companies through various stages of growth.
Top Holdings
Equity Positions (7)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
P PASG | PASSAGE BIO | 37.74% | $20.0M | 2,497,922 | $15.75 | $8.01 | +$19.1M |
E EWTX | EDGEWISE THERAPEUTICS INC | 25.51% | $13.5M | 1,030,161 | $32.50 | $13.11 | -$9.2M |
A ARVN | ARVINAS INC | 22.04% | $11.7M | 1,585,721 | $17.10 | $7.36 | +$539.1K |
C CRNX | CRINETICS PHARMACEUTICALS INC | 7.66% | $4.1M | 141,000 | $27.49 | $28.76 | -$674.0K |
C COGT | COGENT BIOSCIENCES INC. | 3.40% | $1.8M | 250,765 | $11.17 | $7.18 | +$298.4K |